907973-43-7 Usage
Uses
Used in Pharmaceutical Research and Development:
5-FLUORO-1,2,3,4-TETRAHYDRO-NAPHTHALEN-1-YLAMINE HYDROCHLORIDE is used as a potential candidate for therapeutic use in the pharmaceutical industry. Its unique structure and properties make it a promising candidate for the development of new drugs.
Used in the Treatment of Neurological and Psychiatric Disorders:
In the field of medicine, 5-FLUORO-1,2,3,4-TETRAHYDRO-NAPHTHALEN-1-YLAMINE HYDROCHLORIDE is used as a potential treatment for various neurological and psychiatric disorders. Its specific application in this area is due to its potential to modulate certain biological pathways and mechanisms involved in these conditions.
Further Research Needed:
Although 5-FLUORO-1,2,3,4-TETRAHYDRO-NAPHTHALEN-1-YLAMINE HYDROCHLORIDE shows promise in pharmaceutical research and potential therapeutic applications, further research is required to fully understand its medicinal properties and mechanisms of action. This will help in optimizing its use and ensuring its safety and efficacy in treating the targeted conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 907973-43-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,7,9,7 and 3 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 907973-43:
(8*9)+(7*0)+(6*7)+(5*9)+(4*7)+(3*3)+(2*4)+(1*3)=207
207 % 10 = 7
So 907973-43-7 is a valid CAS Registry Number.
907973-43-7Relevant academic research and scientific papers
7-SUBSTITUTED PURINE DERIVATIVES FOR IMMUNOSUPPRESSION
-
, (2008/12/05)
The present invention provides novel purinone and related derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula (III).
7-Substituted Purine Derivatives for Immunosuppression
-
, (2008/12/05)
The present invention provides novel purinone and related derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula III:
SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS
-
Page/Page column 39, (2008/12/04)
Therapeutic compounds, and methods, compositions, and medicaments related thereto are disclosed herein.
PURINE AND IMIDAZOPYRIDINE DERIVATIVES FOR IMMUNOSUPPRESSION
-
Page/Page column 33-34, (2010/11/24)
The present invention provides novel purine and imidazopyridine derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formulas ( I ) and ( II ).
